Xortx Therapeutics Inc
(XRTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 05-2012 | 02-2012 | 11-2011 | 08-2011 | 05-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 17,857 | 10,861 | 28,297 | 9,781 | 124 |
| Depreciation Amortization | 10,210 | 5,130 | 25,811 | 18,310 | 12,261 |
| Income taxes - deferred | -297 | -754 | 1,438 | -2,016 | -3,844 |
| Accounts receivable | 37,147 | 48,599 | 8,753 | 34,302 | 32,299 |
| Accounts payable and accrued liabilities | -33,425 | -46,337 | 15,162 | 3,793 | -10,774 |
| Other Working Capital | -14,742 | 17,325 | 42,960 | 67,117 | 52,822 |
| Other Operating Activity | 1,280 | -599 | -15,489 | -31,871 | -17,127 |
| Operating Cash Flow | $18,030 | $34,225 | $106,932 | $99,416 | $65,761 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -6,964 | -4,168 | -20,232 | -15,521 | -11,225 |
| Net Acquisitions | N/A | N/A | -7,433 | -6,084 | -6,084 |
| Purchase Sale Intangibles | -3,500 | -3,500 | -4,700 | -4,700 | -4,700 |
| Other Investing Activity | -3,500 | -3,500 | -4,700 | -4,700 | -4,700 |
| Investing Cash Flow | $-10,464 | $-7,668 | $-32,365 | $-26,305 | $-22,009 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | -2,374 | -2,374 | -2,374 |
| Common Stock Issued | 601 | 8 | 3,344 | 2 | 2 |
| Common Stock Repurchased | -3,574 | N/A | -32,290 | -23,884 | -5,303 |
| Dividend Paid | -5,471 | -3,355 | -1,459 | -1,459 | N/A |
| Financing Cash Flow | $-8,444 | $-3,347 | $-32,779 | $-27,715 | $-7,675 |
| Beginning Cash Position | 132,630 | 132,630 | 90,842 | 90,842 | 90,842 |
| End Cash Position | 131,752 | 155,840 | 132,630 | 136,238 | 126,919 |
| Net Cash Flow | $-878 | $23,210 | $41,788 | $45,396 | $36,077 |
| Free Cash Flow | |||||
| Operating Cash Flow | 18,030 | 34,225 | 106,932 | 99,416 | 65,761 |
| Capital Expenditure | -6,964 | -4,168 | -20,232 | -15,521 | -11,225 |
| Free Cash Flow | 11,066 | 30,057 | 86,700 | 83,895 | 54,536 |